EU and US could reach trade deal this weekend - Reuters
On Tuesday, Jefferies analyst Julien Dumoulin-Smith adjusted the price target for NiSource stock, listed on the New York Stock Exchange (NYSE: NI), to $45 from the previous $46 while reaffirming a Buy rating on the shares. With the stock trading at $39.35 and analyst targets ranging from $35.34 to $48.15, InvestingPro analysis indicates the stock is currently fairly valued. Dumoulin-Smith’s analysis highlights the company’s ongoing engagement with approximately 30 large-load customers and the visible progress of its Generation Company (GenCo) as factors that continue to support the potential for valuation growth. Despite a lack of acceleration in DC announcements, the analyst sees the current situation as an attractive opportunity leading up to the July 1st hearing.
The Jefferies analyst remains optimistic about NiSource’s prospects, citing the growing visibility of higher risk-adjusted returns and the potential for an acceleration in multi-year contracts. These elements contribute to the firm’s positive outlook on the stock, supported by NiSource’s strong financial health score of GOOD from InvestingPro and impressive 42.72% return over the past year. According to Dumoulin-Smith, the unchanged estimates and a forecasted 9.2% compound annual growth rate (CAGR) in earnings per share (EPS) from 2025 to 2029 position NiSource above the consensus of 8.1% and the upper end of the company’s own guidance at 8.0%.
The reaffirmation of the Buy rating by Jefferies suggests confidence in NiSource’s ability to perform well in the coming years. The anticipated hearing on July 1st is expected to provide further clarity and could potentially enhance the company’s risk-adjusted return profile, making it an appealing option for investors. The company’s track record of maintaining dividend payments for 39 consecutive years, with 8 years of consecutive increases, further reinforces its stability and commitment to shareholder returns.
NiSource’s focus on customer engagement and GenCo advancements appear to be key drivers in the company’s strategy to deliver strong financial performance. The slight reduction in the price target reflects a cautious but still positive view on the company’s valuation prospects.
Investors and market watchers will be keeping an eye on the outcome of the July 1st hearing, which could influence the trajectory of NiSource’s stock. The company’s commitment to securing higher returns and accelerating contract agreements may play a significant role in shaping its future growth and market position.
In other recent news, NiSource Inc (NYSE:NI). reported a strong performance in its first-quarter 2025 earnings, with an adjusted earnings per share (EPS) of $0.98, surpassing analyst expectations of $0.90. Despite revenue falling short at $2.03 billion against a forecast of $2.21 billion, the company reaffirmed its 2025 EPS guidance of $1.85 to $1.89. NiSource also announced a quarterly dividend of $0.28 per share, scheduled for payment on August 20, 2025. Shareholders approved all board nominees and executive compensation during the annual meeting, while a proposal for special shareholder meeting improvements did not pass. Additionally, the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2025 was confirmed. The company continues to focus on strategic initiatives in renewable energy, supporting its commitment to sustainable growth. NiSource’s ongoing investments in infrastructure and community development remain a key part of its operational strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.